1. Starko KM, Ray CG, Dominguez LB, et al. Reve's syndrome and salicylate use. Pediatrics. 1980;66:859-864.
2.
2. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reve's syndrome. JAMA. 1982;247:3089-3094.
3.
3. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye's syndrome and medication use.JAMA. 1982;248:687-691.
4.
4. Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study of Reye's syndrome and medications: report of the main study. JAMA. 1987;257:1905-1911. [Erratum,JAiVA. 1987;257:3366.]
5.
5. Pinsky PF, Hurwitz ES, Schonberger LB, Gunn Wj. Reye's syndrome and aspirin: evidence for a dose-response effect.JAMA. 1988;260:657-661.
6.
6. Forsyth BW, Horwitz RI, Acampora D, et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association.JAMLA. 1989;261:2517-2524.
7.
7. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. NEngl JMed. 1999;340:1377-1382.
9. Follow-up on Reye syndrome-United States. MMWIR1980;29:321-322.
10.
10. Surgeon General's advisory on the use of salicylates and Reye syndrome. MMWR1982;31:289-290.
11.
11. Labeling for oral and rectal over-thecounter aspirin and aspirin-containing drug products. Federal RegisterMarch 7, 1986; 51 FR 8180.
12.
12. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial.JAMA. 1995;273:929-933.
13.
13. Deshmukh DR. Animal models of Reye's syndrome. Rev Infect Dis. 1985;7:31-40.
14.
14. Mukhopadhyay A, Sarnaik AP, Deshmukh DR. Interactions of ibuprofen with influenza infection and hyperammonemia in an animal model of Reye's syndrome. Pediatr Res. 1992;31:258-260.
